MUTYH and pachyonychia congenita: Control- or MYH-siRNA was delivered intratumorally every 48 h using in vivo JetPEI® (Polyplus), a nanoparticle designed for in vivo siRNA delivery and currently in clinical trial for the treatment of PC (clinicaltrials.gov Identifier: NCT01274455).